BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32170783)

  • 1. Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma.
    Rajendra S; Xuan W; Hufnagel K; Sharma P; Pavey D; Alhajjiri N; Rattan A; Wang B
    Ann N Y Acad Sci; 2020 Jun; 1470(1):44-56. PubMed ID: 32170783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
    Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
    Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
    Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
    Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
    Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Human Papillomavirus, Overexpression of p53, and Outcomes of Patients After Endoscopic Ablation of Barrett's Esophagus.
    Rajendra S; Wang B; Pavey D; Sharma P; Yang T; Lee CS; Gupta N; Ball MJ; Gill RS; Wu X
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1364-1368.e5. PubMed ID: 25460562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.
    Gokon Y; Fujishima F; Taniyama Y; Ishida H; Yamagata T; Sawai T; Uzuki M; Ichikawa H; Itakura Y; Takahashi K; Yajima N; Hagiwara M; Nishida A; Ozawa Y; Sakuma T; Kanba R; Sakamoto K; Zuguchi M; Saito M; Kamei T; Sasano H
    Virchows Arch; 2020 Dec; 477(6):825-834. PubMed ID: 32533341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune determinants of Barrett's progression to esophageal adenocarcinoma.
    Lagisetty KH; McEwen DP; Nancarrow DJ; Schiebel JG; Ferrer-Torres D; Ray D; Frankel TL; Lin J; Chang AC; Kresty LA; Beer DG
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33290281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
    Antonsson A; Knight L; Whiteman DC;
    Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma.
    Rice TW; Goldblum JR; Falk GW; Tubbs RR; Kirby TJ; Casey G
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1132-7. PubMed ID: 7983883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.
    Cawley HM; Meltzer SJ; De Benedetti VM; Hollstein MC; Muehlbauer KR; Liang L; Bennett WP; Souza RF; Greenwald BD; Cottrell J; Salabes A; Bartsch H; Trivers GE
    Gastroenterology; 1998 Jul; 115(1):19-27. PubMed ID: 9649454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
    Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
    [No Abstract]   [Full Text] [Related]  

  • 20. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.